What AMSlab does

AMSlab is a privately held Spanish biotechnology group headquartered in Lugo (parent entity ASM SCIENCE, S.L.), operating a portfolio of specialized analytical-testing laboratories built on liquid chromatography-tandem mass spectrometry (HPLC-MS/MS and UPLC-MS/MS). The group serves pharmaceutical, biopharmaceutical, veterinary, agri-food, and clinical end-markets through dedicated sub-brands: AMSbiopharma (pharmaceutical CRO), AMSvet (veterinary toxicology), CIFGA (ISO 17034-accredited reference materials), AMSfood/AMShealth (food safety and clinical), Nexotech (exosome-based life-science products), and AMSlab Academy (training). The company reports more than 1,200 active customers across 45+ countries, 5,000+ m² of laboratory facilities, and 30+ ongoing or completed R&D projects.

The core technology stack centers on mass spectrometry-based analytical services — including mycotoxin detection in feed and blood matrices, marine biotoxin monitoring, pharmaceutical impurity and nitrosamine quantification, and exosome isolation from liquid biopsies — supplemented by patented methods such as ExoGAG and ISO-accredited reference material production. Revenue is generated through project-based CRO/analytical services sold via enterprise field sales, recurring reference-material and kit sales (e.g., ExoGAG, vitamin B12 nitrosamine analysis, serum/plasma mycotoxin panels), and freemium training via AMSlab Academy. Distribution combines direct enterprise sales with regional channel partnerships (notably Nucleus Biotech for the DACH region) and a self-serve customer portal for repeat engagement.

Growth has historically been financed through a combination of organic service revenue and substantial public funding from Spanish (CDTI, Xunta de Galicia, Igape) and European (Horizon 2020, FEDER/ERDF, Marie Sklodowska-Curie, Atlantic Area Interreg) R&D programs. The 2024 calendar year has been the most strategically active period on record: three product/service launches, two new partnerships (LEF in Portugal, Nucleus Biotech in DACH), and the divestiture of AMSfashion to Bureau Veritas, indicating a deliberate sharpening of the group's focus on life-sciences analytical services, reference materials, and diagnostic kits.

Name

AMSlab

Legal name

ASM SCIENCE, S.L.

Website

https://ams-lab.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

51–100 employees

Short description

AMSlab is a Spanish biotech group operating HPLC-MS/MS-based analytical laboratories across pharmaceutical, veterinary, agri-food, and clinical sectors, serving 1,200+ customers in 45+ countries through CRO services, ISO 17034 reference materials, and patented diagnostic kits.

Ownership category

akta.pro rank

Product category

Analytical Laboratory Services (Contract Research Organization)

NAICS

Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)

akta.pro primary industry

Method Development & Validation (ICH/USP) (HLAGADAB)

akta.pro secondary industries

Impurity / Reference Standard Synthesis & Characterization (HLAGAHAG), Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC)

Keywords

• Analytical laboratory services
• Mass spectrometry testing
• Pharmaceutical contract research
• Reference materials production
• Biotechnology product development

Headquarters

HQ city

Lugo

HQ country

Spain

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Analytical Services: Advanced analytical testing services for pharmaceutical, veterinary, and food safety industries including quality control, method validation, and impurity testing.
2. Reference Materials and Standards: Production and sale of reference materials for analytical laboratories, including marine biotoxin standards for research in healthcare and pharmacological fields.
3. Products and Kits: Development and commercialization of products including ExoGAG kit for exosome isolation, and various test kits for food safety and pharmaceutical analysis.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

AMSlab is a biotechnology laboratory group that delivers advanced analytical testing services using HPLC-MS/MS and UPLC-MS/MS technologies to pharmaceutical, biopharmaceutical, veterinary, food safety, and clinical sector clients. It also produces and sells certified reference materials (notably marine biotoxin standards under ISO 17034) and develops proprietary biotech kits such as the patented ExoGAG exosome isolation kit. Group revenue is driven by CRO analytical services, reference material sales, and product commercialization across more than 45 countries.

Product overview

AMSlab is a biotechnology group comprising multiple specialized sub-brands providing advanced analytical services and products. The group includes: AMSbiopharma (pharmaceutical CRO), AMSvet (veterinary toxicology), AMSfood/CIFGA (agrifood reference materials), Nexotech (human/veterinary health products including exosomes), and AMSlab Academy (biotechnology training). Core offerings span analytical testing services (mycotoxin detection, nitrosamine analysis), reference material production, and biotech products like the ExoGAG exosome isolation kit. The portfolio serves pharmaceutical, biopharmaceutical, veterinary, agrifood, and clinical sectors across 45+ countries.

Differentiator

Problem solved

Functional benefit

Brands

• AMSlab: Applied Mass Spectrometry Laboratory - main group brand for advanced analytical services and product development
• AMSvet
• AMSbiopharma
• CIFGA
• Nexotech
• AMSlab Academy

Products and services

• AMSbiopharma Pharmaceutical CRO Services Contract research organization services providing advanced analytical solutions for pharmaceutical, biopharmaceutical, and chemical industries, including drug development support, manufacturing quality control, impurity testing, and analytical method development and validation. Targets pharmaceutical manufacturers through the dedicated AMSbiopharma sub-brand.
• AMSvet Veterinary Analytical Services Veterinary toxicology and clinical analysis services for production livestock animals. Delivered through the AMSvet sub-brand for livestock farms and veterinary practices needing animal health monitoring and mycotoxin/contaminant testing.
• CIFGA Reference Materials ISO 17034-accredited production and sale of reference materials — including pure marine biotoxin standards — for laboratories and research centers worldwide in the agri-food sector. Produced by the CIFGA sub-brand with ENAC accreditation.
• Serum and Plasma Mycotoxin Testing Service Pioneering HPLC-MS/MS analytical service that detects up to 15 different mycotoxins in serum and plasma samples, allowing direct assessment of animal exposure to feed-borne mycotoxins via blood testing. Intended for livestock farms and veterinary diagnostic laboratories.
• Nitrosamine Analysis Service in Vitamin B12 UPLC-MS/MS analytical service that detects and quantifies eight genotoxic nitrosamines in vitamin B12 active pharmaceutical ingredients (cyanocobalamin, hydroxycobalamin, methylcobalamin, and cobamide). Targets pharmaceutical quality control clients needing nitrosamine impurity screening per ICH Q3D and similar guidelines.
• ExoGAG Exosome Isolation Kit Patented kit for rapid and efficient isolation of pure exosomes from liquid biopsy samples (plasma, serum, urine) using an innovative glycosaminoglycan (GAG)-based precipitation reaction. Marketed by the Nexotech sub-brand for life science researchers and clinical biomarker/liquid biopsy programs.
• AMSlab Client Portal Private online portal (portal.ams-lab.com) providing existing clients with access to AMSlab services, analytical reports, and account management.
• AMSlab Academy Training Webinars Free webinar-format biotechnology training courses delivered by qualified professionals for clinical, veterinary, and pharmaceutical sector audiences. Operated under the AMSlab Academy brand, with one-hour sessions and limited spots available.

Quantifiable outcome

• Detection of up to 15 different mycotoxins in serum and plasma samples
• +1 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• LEF (Laboratório de Estudos Farmacêuticos)coreStrategic or Co-development Partner · 4 June 2024Strategic partnership between AMSbiopharma and LEF, a CRO and CDMO based in Portugal and part of the National Association of Pharmacies (ANF) Group. The partnership allows both companies to complement each other's strengths and expand the range of services offered to the pharmaceutical industry, providing comprehensive support from early-stage R&D to full-scale production and commercialization.
• Nucleus BiotechcoreChannel Partner/ Reseller/ Distributor · 19 March 2024Distribution agreement for ExoGAG product in Germany, Switzerland and Austria. Nucleus Biotech, a German company specialized in providing reagents and services to life science researchers, will distribute the patented exosome isolation product for biomarker research and liquid biopsy applications.
• ExopolminorStrategic or Co-development PartnerCollaboration in developing the pioneering HPLC-MS/MS mycotoxin determination service in serum and plasma for veterinary toxicology applications.
• GalChimiacoreStrategic or Co-development PartnerCollaboration in multiple R&D projects including Oncogalfarma (cancer treatment research) and Neogalfarm (new drugs for cancer). GalChimia is a Galician biotech company specializing in organic synthesis and medicinal chemistry.
• OncostellaecoreStrategic or Co-development PartnerCollaboration in cancer drug development projects including IO4COLON (immunotherapy for colon cancer) and Neogalfarm. Oncostellae focuses on kinase inhibitors and protein-protein interaction modulators.
• University of Santiago de Compostela (USC)coreStrategic or Co-development PartnerAcademic partner in numerous R&D projects including QFashion, MYCONTROL, Spectrafish, Oxidrinks, Neogalfarm, IO4COLON, and Aptafood. Collaborates on research in analytical methods, cancer research, and food safety.
• Bureau VeritascoreStrategic or Co-development PartnerBureau Veritas acquired AMSfashion (former subsidiary of AMSlab) and established a partnership for consumer products services in fashion and textile quality control.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• SGS: Swiss-based global testing, inspection, and certification company with extensive life sciences and food safety analytical services. Overlaps with AMSlab's pharma QC, food safety, and agri-food reference material offerings, though at much larger scale.
• Eurofins Scientific: Global leader in bioanalytical testing and contract laboratory services for pharmaceutical, food, and environmental markets. Directly comparable as a mass-spectrometry-driven analytical services platform, but with vastly broader scale, geographic coverage, and instrument capacity than AMSlab.
• Bureau Veritas: Global TIC company that acquired AMSlab's former subsidiary AMSfashion. Comparable testing/certification orientation and partner-customer relationship with AMSlab group, with broader pharmaceutical and agri-food testing capabilities.
• Intertek: Global TIC provider with analytical and laboratory services across pharmaceutical, food, and agri-food verticals. Comparable service mix to AMSlab's CRO and reference material business, but as a much larger diversified platform.
• Cerilliant (Merck KGaA / Sigma-Aldrich): Reference standards and certified reference materials business within Merck's life science portfolio. Directly comparable to CIFGA's reference materials business, particularly for pharmaceutical impurities and toxins, though serving a far broader global customer base.
• Charles River Laboratories: Global CRO with extensive analytical and safety assessment services for pharmaceutical and biopharmaceutical clients. Comparable to AMSlab's AMSbiopharma pharmaceutical CRO offering, particularly in method validation and impurity testing, though with far broader scale and service portfolio.

Direct peers

• ALS Limited: Australia-based analytical laboratory services provider with pharmaceutical, food, and environmental testing capabilities. Directly comparable to AMSlab's contract analytical model with similar mass spectrometry capabilities, though at larger international scale.
• Romer Labs: Austrian-based specialist in mycotoxin and food contaminant testing, reference materials, and diagnostic kits. Closely comparable to AMSlab's CIFGA reference materials and AMSvet mycotoxin testing lines, with overlapping customer base in feed/food safety.
• PharmaBlock Sciences: Provider of reference standards, impurities, and building blocks for pharmaceutical R&D and QC. Comparable to AMSlab's reference materials and impurity characterization work, particularly for nitrosamine and genotoxic impurity standards.

Emerging players

• Nemysis Limited: Specialist in iron-based and pharmaceutical testing/reagent solutions with European footprint. Adjacent comparable to AMSlab's niche mass spectrometry analytical focus, though smaller and with a more concentrated product set.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks2 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/AMSlablugo
• YouTubeyoutube.com/channel/amslab
• Xx.com/AMSlab
• LinkedInlinkedin.com/company/amslab

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AMSlab